Bright Minds Biosciences
DRUG • NASDAQ
Bright Minds Biosciences is a biotechnology company in the healthcare sector on NASDAQ, led by Mike Johnson, with a market cap of $596.8M. As of Q3 2025, 85% of shares are held by 62 institutional investors, with HENDERSON GROUP PLC as the largest holder at 16.16%.
CEOMike Johnson
Overview
Overview of institutional ownership in DRUG as of Q3 2025 with a market cap of $430.0M
All Institutions
- Institutions
- 62
- Value Held
- $365.7M
- Shares Held
- 6.0M
- Avg Position
- $5.9M
- Median Position
- $413.0K
Hedge Funds
- Hedge Funds
- 15
- Value Held
- $188.1M
- Shares Held
- 3.1M
- Avg Position
- $12.5M
- Median Position
- $4.7M
Ownership Breakdown
Based on market cap of $430.0M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in DRUG as of Q3 2025
| Institution | Position Value |
|---|---|
 HENDERSON GROUP PLC Institution | $69.1M 0.03% of portfolio |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | $64.3M 5.01% of portfolio |
 Vivo Capital, LLC Venture Capital | $30.4M 2.45% of portfolio |
 COMMODORE CAPITAL LP Hedge Fund•Long/Short | $30.3M 1.48% of portfolio |
 PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | $27.3M 0.79% of portfolio |
A ADAGE CAPITAL PARTNERS GP LLC Institution | $24.0M 0.04% of portfolio |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $18.4M 0.75% of portfolio |
B BlackRock, Inc. Institution | $14.2M 0.00% of portfolio |
 MORGAN STANLEY RIA/Wealth | $11.7M 0.00% of portfolio |
 Sio Capital Management, LLC Hedge Fund•Long/Short | $11.6M 2.93% of portfolio |
Net Capital Flow
Institutional buying and selling activity for DRUG in Q3 2025
- Traded
- +$48.9M
- Buyers
- 38
- Sellers
- 14
- Total Bought
- +$76.5M
- Total Sold
- −$27.7M
- Avg Position
- $5.7M
Biggest Buyers
| Institution | Net Bought |
|---|---|
B BRAIDWELL LP Hedge Fund•Multi-Strategy | +$18.4M +303.7K shares |
Vivo Capital, LLC Venture Capital | +$15.2M +250.0K shares |
A ADAGE CAPITAL PARTNERS GP LLC Institution | +$11.9M +195.7K shares |
 BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$11.3M +186.9K shares |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | +$3.3M +54.0K shares |
 STATE STREET CORP Institution | +$2.7M +43.7K shares |
L Longwood Capital Partners LLC Institution | +$2.2M +36.4K shares |
MORGAN STANLEY RIA/Wealth | +$1.9M +30.8K shares |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | +$1.7M +28.6K shares |
B BlackRock, Inc. Institution | +$1.5M +24.4K shares |
Biggest Sellers
| Institution | Net Sold |
|---|---|
Sio Capital Management, LLC Hedge Fund•Long/Short | −$19.5M −321.6K shares |
 Ikarian Capital, LLC Hedge Fund•Event Driven | −$3.0M −50.0K shares |
 MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$2.1M −34.7K shares |
 Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | −$1.8M −30.0K shares |
R READYSTATE ASSET MANAGEMENT LP Hedge Fund•Multi-Strategy | −$364.9K −14.0K shares |
 DEUTSCHE BANK AG\ Institution | −$295.2K −4.9K shares |
 Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | −$145.5K −2.4K shares |
 BARCLAYS PLC Institution | −$109.9K −1.8K shares |
N NEW YORK STATE COMMON RETIREMENT FUND Institution | −$91.0K −1.5K shares |
 CITIGROUP INC Institution | −$87.2K −1.4K shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited DRUG in Q3 2025
- New Positions
- 12
- New Value
- $33.9M
- Exited Positions
- 1
- Exited Value
- $364.9K
New Positions
| Institution | Position Value |
|---|---|
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $18.4M 303.7K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $11.3M 186.9K shares |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | $3.3M 54.0K shares |
L LPL Financial LLC Institution | $342.4K 5.6K shares |
$229.4K 3.8K shares | |
 MetLife Investment Advisors, LLC Insurance Manager | $177.0K 2.9K shares |
 Gordian Capital Singapore Pte Ltd Fund of Funds | $72.8K 1.2K shares |
R Russell Investments Group, Ltd. RIA/Wealth | $57.7K 951.0 shares |
 Global Retirement Partners, LLC RIA/Wealth | $12.1K 200.0 shares |
 SRS Capital Advisors, Inc. RIA/Wealth | $1.5K 24.0 shares |
Exited Positions
| Institution | Previous Position |
|---|---|
R READYSTATE ASSET MANAGEMENT LP Hedge Fund•Multi-Strategy | $364.9K 14.0K shares |
Options Activity
Institutions with the largest Call and Put options positions in DRUG as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with DRUG as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
L Longwood Capital Partners LLC Institution | 5.32% $5.1M |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | 5.01% $64.3M |
S SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund•Long/Short | 3.22% $3.3M |
Sio Capital Management, LLC Hedge Fund•Long/Short | 2.93% $11.6M |
Vivo Capital, LLC Venture Capital | 2.45% $30.4M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 1.48% $30.3M |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | 0.79% $27.3M |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | 0.75% $18.4M |
Ikarian Capital, LLC Hedge Fund•Event Driven | 0.19% $936.0K |
A AdvisorShares Investments LLC Institution | 0.14% $831.6K |
Hedge Fund Spotlight
Discover hedge funds investing in DRUG
Ikarian Capital, LLC
Hedge Fund • Event Driven
Portfolio ManagerNeil Tristan Shahrestani
- Portfolio Value
- $494.3M
- Positions
- 116
- Last Reported
- Q3 2025
Sector Allocation
Position in Bright Minds Biosciences
- Market Value
- $936.0K
- Shares Held
- 15.4K
- Portfolio Weight
- 0.19%
- Owned Since
- 2024-Q4
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Unknown Unknown | $53.0M | 10.73% | |
Unknown Unknown | $33.4M | 6.76% | |
Biotechnology Healthcare | $27.2M | 5.49% |
